Walkky

Walkky is an AI platform for cardiovascular diagnosis that addresses the significant public health concern of heart-related death. Founded in 2018 and headquartered in the United States, Walkky aims to revolutionize the way signals from the body are processed to enhance patients' lives. The company's innovative solution utilizes RESTful AI-powered analytics and alerting platform to accurately predict heart issues based on Electrocardiogram (ECG) reads. Utilizing a novel method of bio-signal processing called Bio-Semantics™, Walkky's technology is inspired by natural language processing and semantic networks in the field of computer science, aiming to better diagnose and predict heart issues. The last investment in Walkky was a Non-Equity Assistance investment at 26th July 2023 by MassChallenge. The company's interdisciplinary team, comprised of startup executives, corporate leaders, top physicians, and Ivy League alumni and faculty, brings extensive experience in developing and bringing innovative software solutions to market. Walkky's solution addresses the need for early predictions and out-of-hospital monitoring tools in the diagnosis of heart issues. By providing immediate actionable analysis to patients or medical providers, the platform aims to reduce the time to provider intervention and substantially increase the patient’s quality of life. With a vision to revolutionize the incorporation of AI in the medical field, Walkky anticipates building groundbreaking technology that will enhance patient lives and serve providers and medical device companies.